| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.087 | 0.1 |